Rapt Therapeutics Inc

RAPT Therapeutics Inc. is a clinical stage immunology-based biopharmaceutical company. It focuses on discovering, developing and commercializing oral small molecule therapies for oncology and inflammatory diseases. The company's drug candidate consists of FLX475 for the treatment of tumors and RPT193, a CCR4 antagonist for allergic inflammatory disease. RAPT Therapeutics Inc. is based in San Francisco, California.

Address Details

Address: 561 ECCLES AVENUE

City: SOUTH SAN FRANCISCO

State: CA

Country: USA

Zip Code: 94080